Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses

This publication has 101 references indexed in Scilit:

• Was tumour necrosis factor-α responsible for the fetal malformations associated with thalidomide in the early 1960s?
  Medical Hypotheses, 1998
• Inflammatory Bowel Disease Management
  Drugs, 1997
• Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential uses
  Journal of the American Academy of Dermatology, 1996
• Editorial
  Reproductive Toxicology, 1996
• Thalidomide and Its Metabolites Have No Effect on Human Lymphocyte Proliferation
  International Archives of Allergy and Immunology, 1996
• Down-regulation of adhesion receptors on cells of primate embryos as a probable mechanism of the teratogenic action of thalidomide
  Life Sciences, 1995
• Thalidomide derivatives and the immune system 6. Effects of two derivatives with no obvious teratogenic potency on the pattern of integrins and other surface receptors on blood cells of marmosets
  Life Sciences, 1995
• Thalidomide is an inhibitor of angiogenesis.
  Proceedings of the National Academy of Sciences, 1994
• Thalidomide for systemic lupus erythematosus
  The Lancet, 1992
• Thalidomide for systemic lupus erythematosus
  The Lancet, 1992